Securing the Future: IT/OT Cyber Security in Pharma

Navigating the complex landscape of IT/OT cyber security in pharma is no longer optional – it is essential. As pharmaceutical companies embrace automation, cloud platforms, and the Industrial Internet of Things (IIoT), our operational technology (OT) and information technology (IT) environments are more connected than ever. At Mangan Biopharm, we recognize that these advancements, while transformative in delivering better patient outcomes and operational efficiencies, also introduce new vulnerabilities. Ensuring the integrity, availability, and confidentiality of critical data and systems is vital in an era when cyber attackers are increasingly sophisticated and regulatory requirements only intensify.

Why Robust Digital Security Matters in the Pharmaceutical Sector

The pharmaceutical industry is built on trust: patients rely on medications to be safe and effective, healthcare partners expect consistent supply, and regulators mandate compliance with stringent standards. Any compromise to our digital infrastructure could hinder these obligations and damage reputations built over decades. As we have seen, digital threats can quickly escalate from minor disruptions to widespread supply chain chaos or even patient safety risks.

The need for robust cyber security extends beyond IT systems. Manufacturing, quality control, laboratory automation, and connected medical devices now reside at the convergence of IT and OT. This intersection opens new attack vectors that traditional security strategies often miss. Securing connected devices, production facilities, and cloud-hosted applications is now a critical mandate – one that requires integrated approaches tailored to our unique regulated environment. At Mangan Biopharm, we are committed to meeting these challenges head-on by embracing advanced security practices across our digital and operational landscapes.

Current Threats and the Evolution of IT/OT Cyber Security in Pharma

Threats facing pharmaceutical networks grow in both sophistication and scope. Malicious actors – from state-sponsored groups to cybercriminals – target pharma due to the high value of intellectual property, personal health data, and critical supply chain assets. Ransomware, phishing, insider threats, and supply chain attacks are now regular concerns.

Specific risks are amplified by the integration of IT and OT. Malware introduced through business networks can leapfrog into production environments, disrupting batch processes, manipulating sensor readings, or even shutting down entire facilities. Cloud-based platforms, if not properly configured, may expose everything from batch records to intellectual property. The rapid deployment of digital tools – especially those involving IoT and cloud – demands a vigilant, adaptive approach.

We must also address regulatory drivers. Compliance frameworks such as FDA’s CFR Part 11, GAMP 5, and guidelines for data integrity all call for robust, documented controls. As evidenced in recent FDA cybersecurity guidance, authorities expect well-documented risk management across the entire product and infrastructure lifecycle. Our solutions at Mangan Biopharm ensure that cyber security in pharmaceutical manufacturing is resilient and fully aligned with industry compliance requirements.

Integrating IT/OT Cyber Security for Compliance in Pharma Operations

Achieving strong IT/OT cyber security in pharma requires a proactive, layered strategy. It is not simply the task of IT or a single department – cybersecurity must be woven into our culture, processes, and technology choices. Integration means aligning security controls for both traditional IT systems (like ERP or email) and operational environments (such as process automation, manufacturing execution systems, and connected lab equipment).

Connected devices, including sensors, analyzers, and mobile systems, expand the attack surface. If left unprotected, these endpoints can offer hackers a direct path into regulated production environments. At Mangan Biopharm, we promote a defense-in-depth approach, using well-defined network segmentation, strict access controls, encryption, and continuous monitoring. We conduct independent risk assessments for each system, ensuring risk-based validation aligns with CSA (Cloud Security Alliance) and GAMP 5 principles, as detailed in resources like our computer system validation solutions.

Cloud adoption adds another layer of complexity – and opportunity. While cloud platforms offer scalability and efficiency, they introduce new risks and shared responsibility models. Understanding where the cloud provider’s responsibilities end and ours begin is critical, especially for GxP systems and data under regulatory scrutiny.

Responsibilities in GxP Cloud Deployments: Cloud Provider vs. Mangan Biopharm

Assigning security roles clearly is crucial for compliance and risk management. The following responsibilities are usually defined:

• Cloud Provider Responsibilities: Physical security of data centers, underlying hardware (servers, networking, storage), virtualization layers, and operating system patches (for PaaS/SaaS).
• Mangan Biopharm Responsibilities: Configuration management, data encryption, user management, application security, and – most importantly – risk-based validation aligning with CSA or GAMP 5 best practices.
• Cloud Provider:

• Operating System
• Virtualization
• Servers
• Storage
• Physical data center and core network infrastructure

• Mangan Biopharm:

• Apply risk-based validation aligned with CSA or GAMP 5
• Regulated data management
• User access and logical controls
• Process and application layer security

Managing Controls Across Cloud Service Models

Where we and our providers share responsibilities depends on whether the service is Infrastructure as a Service (IaaS), Platform as a Service (PaaS), or Software as a Service (SaaS):

• IaaS (Infrastructure as a Service): The provider manages hardware and basic virtualization, while we manage the OS, applications, data, and all GxP validation.
• PaaS (Platform as a Service): The provider is responsible for the hardware, OS, and runtime. We manage our applications, data, and validation relevant to those apps.
• SaaS (Software as a Service): The provider is responsible for everything up to the application itself. We retain responsibility for user configuration, managed data, validation of the system for our intended use, and access controls.

Best Practices for Resilient IT/OT Cyber Security in Pharma

Establishing resilient IT/OT cyber security in pharma is a multi-layered effort. Our approach at Mangan Biopharm prioritizes prevention, detection, and rapid response within a risk-based, quality-driven framework. Validation, documentation, and oversight are woven into each step. Our recommendations for managing cloud and GxP validation responsibilities are grounded in best practices:

• Conduct formal vendor qualification and risk assessments before selecting a cloud provider
• Document a shared responsibility matrix mapping each GxP control to the accountable party
• Establish detailed service agreements specifying roles, escalation procedures, and incident management responsibilities
• Apply risk-based validation approaches aligned with CSA or GAMP 5
• Maintain comprehensive audit trails and system logs that support compliance and digital forensics
• Continuously monitor vendor updates and assess potential GxP impact
• Trigger revalidation whenever system changes could affect regulated processes

In practice, we create robust policies covering user access, data encryption in transit and at rest, vulnerability management, and proactive threat detection. Our procedures complement technical controls – ensuring that our teams remain vigilant through ongoing cyber awareness training and participation in security exercises.

Risk assessments are key, especially when onboarding new technologies. By leveraging automated threat modeling and real-time monitoring, we detect anomalies faster. For more on our automation expertise, visit our automation solutions page.

To support compliance, our data integrity and validation management frameworks ensure that every action is logged, reviewable, and protected against tampering – a necessity for FDA and global regulators.

Building a Security-First Culture and Looking Ahead

Technology alone is not enough to guarantee IT/OT cyber security in pharma. People, process, and leadership culture are equally vital. At Mangan Biopharm, we empower our teams with the training and expertise to detect threats, respond rapidly, and support a culture where security is everyone’s responsibility. Cybersecurity is regularly championed at the executive level and baked into our everyday workflows.

Looking to the future, pharma cyber risk management will be shaped by advancements in artificial intelligence (AI), machine learning, and edge computing – offering both new defenses and novel attack surfaces. Expect increased adoption of zero-trust architectures and next-generation behavioral analytics to spot emerging cyber threats. Regulations will continue evolving to keep pace with remote work, cloud validation, and global supply chain digitization.

We anticipate that trustworthy automation solutions, intelligent anomaly detection, and robust incident response plans will become baseline for all regulated manufacturers. Having a proactive approach is no longer a competitive advantage – it is a business imperative. Access our latest guidance on data integrity essentials to see how we’re building sustainable, secure digital foundations for life sciences.

Ready to Transform Your Cybersecurity Posture?

Future-ready pharma organizations require more than just strong firewalls or encrypted backups. Resilient IT/OT cyber security in pharma hinges on integrated strategy, shared responsibility, and ongoing engagement – from the boardroom to the shop floor. At Mangan Biopharm, we make it our mission to guide you through every step, whether you are integrating your first IoT system or operating complex, validated cloud platforms.

Contact us for a free assessment, and discover how our tailored automation, data integrity, and validation management solutions can protect your assets and reputation. Let’s advance together, safeguarding our patients, our science, and our future. Reach out to Mangan Biopharm today – your trusted partner in IT/OT cyber security excellence.

FAQ